Cochlear implant for meningitis babies:
This article was originally published in Clinica
Executive Summary
Meningitis-related deafness can be cured by cochlear implants as long as they are implanted early enough. The technique has been pioneered by doctors from the Queens Medical Centre in Nottingham (UK), reports New Scientist (September 23rd). They say the device, manufactured by Cochlear (Australia), must be fitted before new bone growth blocks the cochlear. The implants cost £21,000 ($35,000) each and the total procedure approximately £31,000. The devices must be individually tuned, which requires one full-time physician for every 10 patients. Around 300 children a year need cochlear implants in the UK.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.